The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance
Open accessAbstract
A key feature of human natural killer (NK) cells, which enables efficient recognition of infected and malignant target cells, is the expression of HLA class I-specific receptors of the KIR and NKG2 gene families. Cell-to-cell variability in receptor expression leads to the formation of complex NK cell repertoires. As outlined here, NK cells go through major changes from newborns to adults characterized by downregulation of the inhibitory NKG2A receptor and concomitant upregulation of KIR family members. This process is completed in young adults, and in the majority of individuals, KIR/NKG2A repertoires remain remarkably stable until old age. Nonetheless, age-related factors have the potential to majorly influence the complexity of NK cell repertoires: Firstly infection with HCMV is associated with major clonal expansions of terminally differentiated NKG2C- and KIR-expressing NK cells in certain individuals. Secondly, ineffective hematopoiesis can lead to immature and less diversified NK cell repertoires as observed in myelodysplastic syndrome (MDS), a malignant disease of the elderly. Thus, whereas in the majority of elderly the NK cell compartment appears to be highly stable in terms of function and phenotype, in a minority of subjects a breakdown of NK cell repertoire diversity is observed that might influence immune surveillance and healthy aging.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, many immune cell subsets become hyporesponsive to acute challenges as we age17,19-25.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [21]
In the citing paper
“It should be noted that, in the process of immunosenescence, the activating receptor expression of natural killer (NK) cell markers NKP30, NKP46, etc., is reduced, while the inhibitory receptor expression of KIR, NKG2C, etc., is increased [45, 46].”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [45]
In the citing paper
“Two subpopulations of NK cells, immature CD14+CD56dim and mature CD14+CD56bright, are associated with aging and remodeling of mature NK cell subsets, and the reduced expression of activated receptors may promote the escape of NK cells in the elderly [45].”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [45]
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J., Lanier, L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 3,272
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D., O'Callaghan, C. A., Söderström, K., D’Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,226
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S.-M., Ghaheri, B. A., Ghayur, T., Carson, W. E., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.10.3146 · Cited by 1,448
Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W. A., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,394
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine‐Laurent, J., Truscott, S. M., Lybarger, L. P., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,328
Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors
Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B., & Lanier, L. L. (2002) · Science · doi:10.1126/science.1070884 · Cited by 1,229
Human NK Cell Education by Inhibitory Receptors for MHC Class I
Anfossi, N., André, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V., Frassati, C., Reviron, D., Middleton, D., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.013 · Cited by 1,207
Age-related changes in lymphocyte development and function
Linton, P. J., & Dorshkind, K. A. (2004) · Nature Immunology · doi:10.1038/ni1033 · Cited by 1,199
Imai, K., Matsuyama, S., Miyaké, S., Suga, K., & Nakachi, K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03231-1 · Cited by 1,189
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–148 of 148
Resident CD49a + CD103 + NKG2C + NK cells restrict HIV infection in human lymphoid tissue explants
Perea, D., Gonzalez, A., Gallego-Cortés, A., Sánchez-Gaona, N., Pumarola, F., Ortiz, N., Llano, I., Lorente, J., Falcó, V., Genescà, M., et al. (2026) · Science Advances · doi:10.1126/sciadv.adz1565 · Cited by 2
Decoding the tumor-aging axis: from bench to clinical
Wang, Y., Lv, G., Gao, X., Zheng, J. H., Huang, J., & Wang, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1823423 · Cited by 2
Pancreatic adenocarcinoma and aging: understanding the menace for better management
Zhou, T., Yan, J., Hao, J., & Yu, J. Q. (2023) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000133 · Cited by 2
Beyond Checkpoint Inhibition: Keeping Therapeutic Options Open
Joshi, U. M., Hundal, J., Mata, J. R., Schollenberger, M. D., Warrier, G., Luke, J. J., Lipson, E. J., & Funchain, P. (2025) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk-25-473856 · Cited by 2
Guo, X. Y., Guo, C., Li, D., Bai, Y., Abbas, M., Fan, R., & Zhao, Y. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1571857 · Cited by 2
The potential of cord blood to replenish young immune cells against cancer
Li, X., Cheng, L., Li, J., & Ren, R. (2021) · Aging and Cancer · doi:10.1002/aac2.12032 · Cited by 1
Tuberculosis in Children: A Perspective from Life History Theory
Gómez-Velasco, A., Banik, S. D., & Sánchez‐Pérez, H. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-27848-8_4 · Cited by 2
Tu, C., Buckle, I., Rojas, I. L., Rossi, G. R., Sester, D. P., Moore, A. S., Radford, K. J., Guillerey, C., & Souza-Fonseca-Guimarães, F. (2024) · Clinical & Translational Immunology · doi:10.1002/cti2.1501 · Cited by 1
iPSCs derived sEVs ameliorate NK cell senescence by targeting CISH-STAT3
Chen, Y., Cao, R., Chen, Z., Zhang, J., Ren, Y., Niu, X., Ji, Y., Luo, L., Yu, S., Wang, Y., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04761-0 · Cited by 1
Bennstein, S. B., Reiß, J., Raba, K., Pham, T. X. U., Paulusch, S., Domenico, E. D., Niehues, T., Fischer, J., Kögler, G., Beyer, M. D., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117000 · Cited by 1
Self-citationThe therapeutic potential of natural killer (NK) cells to combat aging and age-related diseases
Bari, R., Kang, L., Gosiewska, A., & HARIRI, R. J. (2026) · Discover Immunity. · doi:10.1007/s44368-026-00021-2 · Cited by 1
Immunosenescence and Cancer: Cellular Aging Programs That Reshape Antitumor Immunity
Oh, S.-H., Kim, Y. W., Kim, S. H., & Chang, S.-Y. (2026) · Immune Network · doi:10.4110/in.2026.26.e15 · Cited by 2
Stem cells as an essential mediator of the exercise–tumorigenesis link
Zhuang, X., Wong, E. S. W., Tammela, T., & Jones, L. W. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00933-z · Cited by 2
Host-Pathogen Interaction as a Driver of Cellular Senescence: Microbial Triggers and Host Response
Iordache, F., Zaharie, A. A., Rosu, P. M., Holban, A. M., & Curuțiu, C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146497 · Cited by 1
Natural Killer Cells and Alzheimer’s Disease
Page, A. Y. L., Dupuis, G., & Fülöp, T. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_146 · Cited by 1
Ohira, M., Imaoka, K., Bekki, T., Sato, K., Imaoka, Y., Nakano, R., Yano, T., Doskali, M., Shimizu, S., Chogahara, I., et al. (2024) · Transplantation Proceedings · doi:10.1016/j.transproceed.2023.11.033 · Cited by 1
Xie, J., Fan, Z., Cao, X., Ding, Y., Liu, H., Shang, Q., Zhao, X., Chang, Y., Wang, Y., Xu, L., et al. (2024) · Annals of Hematology · doi:10.1007/s00277-024-05827-4 · Cited by 1
Palliyage, G. H. (2023) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.12138 · Cited by 1
Heterochronic Parabiosis Studies of the Aging Immune System
Davies, J. (2016) · UA Campus Repository (The University of Arizona)
Natural Killer Cells: What Have We Learned?
Sarhan, D., & Miller, J. S. (2018) · Advances and controversies in hematopoietic transplantation and cell therapy · doi:10.1007/978-3-319-54368-0_10
Natural Killer Cells and Alzheimer’s Disease
Page, A. Y. L., Dupuis, G., & Fülöp, T. (2018) · Springer eBooks · doi:10.1007/978-3-319-64597-1_146-1
Age-Related Changes in the Murine Immune System
Nikolich‐Žugich, J., Contreras, N. A., Coplen, C. P., & Jeftic, I. D. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_67-1
Single-cell sequencing characterizes intratumoral profile of immune cells in old micePreprint
Zhang, C., Lei, L., Yang, X., Zheng, H., Su, Y., Jiao, A., Wang, X., Liu, H., Zou, Y., Shi, L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.23.432366
Lost in transition? Immune regulatory mechanisms in early life
Hoeks, S. B. E. A. (2021) · doi:10.33540/392
Age-Related Changes in the Murine Immune System
Nikolich‐Žugich, J., Contreras, N. A., Coplen, C. P., & Jeftic, I. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_67
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24844701
Magatti, M., Pischiutta, F., Ortolano, F., Pasotti, A., Caruso, E., Cargnoni, A., Papait, A., Capuzzi, F., Zoerle, T., Carbonara, M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23937245
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654485
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654461
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654482
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654479
Magatti, M., Pischiutta, F., Ortolano, F., Pasotti, A., Caruso, E., Cargnoni, A., Papait, A., Capuzzi, F., Zoerle, T., Carbonara, M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23937248
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654470
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654467
Magatti, M., Pischiutta, F., Ortolano, F., Pasotti, A., Caruso, E., Cargnoni, A., Papait, A., Capuzzi, F., Zoerle, T., Carbonara, M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23937251
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24844603
Fu, X., Qin, P., Li, F., Zhu, H., You, H., Zhang, Y., Xu, B., Li, T., Zhang, F., Han, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26654464
Xu, H., Luo, Y., & Wu, X. X. (2026) · Comprehensive physiology · doi:10.1002/cph4.70098 · Cited by 1
Dual roles of immunosenescence in cancer immunotherapy
Yu, Y., Sun, L., & Fan, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1779141
Hua, Y., Zhang, Y., Zhou, J., Shi, Y., & Xu, F. (2026) · BMC Pediatrics · doi:10.1186/s12887-026-06708-7
Liu, J., Guo, D., Pu, M., Li, X., Xiao, Y., Zhang, Z., Tang, Y.-B., Liu, Y., Ma, C.-G., & Wang, Q. (2026) · Scientific Reports · doi:10.1038/s41598-026-43283-4
Etude des mécanismes de régulation de l'activation des cellules natural killer
Guia, S. (2021) · theses.fr (ABES) · doi:10.70675/fe8a748dzb006z40a0z8e07z1043717cbdd0
Bennstein, S. B., Reiß, J., Weinhold, S., Scherenschlich, N., Degistirici, Ö., Raba, K., Walter, L., Fischer, J., Kögler, G., Meisel, R., et al. (2026) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szag034
Self-citationZhao, R., Li, Y., Zhu, R., Zong, R., Sun, M., Liu, M., & Guo, H. C. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105385
Ahn, H., Lee, J., Park, J.-H., Barn, J. S., Kim, Y., & Kang, J. S. (2026) · Antioxidants · doi:10.3390/antiox15070796
Wilk, A. J., Shameli, A., Ames, E., Fromm, J. R., Grzywacz, B. J., Shi, M., Cherian, S., & Oak, J. S. (2026) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.70076
Coronado, R. E. (2026) · GeroScience · doi:10.1007/s11357-026-02554-8
Immune system ontogeny—a subtle evolution to perfection
Munteanu, A. N., Surcel, M., Dobre, E. G., Constantin, C., & Neagu, M. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1872955
Metadata
- Authors
- Manser, A. R., & Uhrberg, M.
- Affiliations
- Heinrich Heine University Düsseldorf (DE)
- Corresponding author
- Uhrberg, Markus
- ORCID
- Uhrberg, Markus
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2015-08-19
- Volume
- 65
- Issue
- 4
- Pages
- 417-426
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- PMC
- PMC11028690
- OpenAlex
- W1837057295
- Cited by
- 148
- References
- 56
- Citations by year
- 2026: 19 · 2025: 14 · 2024: 28 · 2023: 19 · 2022: 10 · 2021: 15 · 2020: 12 · 2019: 9 · 2018: 9 · 2017: 7 · 2016: 5 · 2015: 1
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cancer Immunology Immunotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Krebshilfe (DE) (110351)
- Deutsche Forschungsgemeinschaft (DE) (UH 91/7-1)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- natural killer cells, NK cell repertoire, aging, killer cell immunoglobulin-like receptors, NKG2A, NKG2C, HCMV infection, myelodysplastic syndrome, ineffective hematopoiesis, immune surveillance, healthy aging, clonal expansion
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Aging, Child, Child, Preschool, Humans, Immunologic Surveillance, Infant, Infant, Newborn, Killer Cells, Natural, Middle Aged, Myelodysplastic Syndromes, Receptors, Natural Killer Cell
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
